半参数生存模型的共变量调整响应适应设计
Ayon Mukherjee1, Sayantee Jana2, Stephen Coad3
1Regulatory Affairs and Drug Development Solutions, IQVIA, Frankfurt, Germany.
Statistical methods in medical research
|November 26, 2024
概括
同变量调整响应适应 (CARA) 设计可以改善患者的治疗分配,而无需分配假设. 新的CARA设计确保了使用比例危险的生存试验的有效统计推断,提高了临床试验的效率.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 生存分析的分析.
背景情况:
- 同变量调整响应适应 (CARA) 设计旨在在临床试验中最大限度地使患者受益.
- 现有的CARA设计通常依赖于参数假设,限制了它们在现实世界中的适用性.
- 加速失效时间 (AFT) 模型为一些CARA设计提供了有效的推断,但在初级分析中很少使用.
研究的目的:
- 开发新的CARA设计,用于不需要分布假设的生存试验.
- 根据比例危险假设,确保有效的统计推断.
- 为了实现多个实验目标的最佳分配方法.
主要方法:
- 拟议的CARA设计规避了分布假设,依赖于比例危险假设.
- 使用共变量调整的双重自适应偏差硬币和共变量调整的高效随机自适应设计,用于患者随机化.
- 采用Cox回归系数的顺序估计,以实现最佳的分配目标.
主要成果:
- 广泛的模拟研究表明,拟议的设计具有有利的操作特性.
- 这些设计成功地实施,重新设计了一项现实生活中的验证性临床试验.
- 新的CARA设计可以在没有参数假设的情况下提供有效的统计推断.
结论:
- 开发的CARA设计为涉及生存结果的适应性临床试验提供了灵活和强大的方法.
- 这些方法通过优化治疗分配来提高临床试验的效率.
- 这些发现支持在生存试验环境中更广泛地采用无假设的适应性设计.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
152
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
152
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Parametric Survival Analysis: Weibull and Exponential Methods
364
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
364
Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184
Kaplan-Meier Approach
100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100
Censoring Survival Data
63
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
63


